First Horizon Advisors, Inc. Royalty Pharma PLC Transaction History
First Horizon Advisors, Inc.
- $3.81 Billion
- Q2 2025
A detailed history of First Horizon Advisors, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 60 shares of RPRX stock, worth $2,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 12
400.0%
Holding current value
$2,227
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RPRX
# of Institutions
498Shares Held
288MCall Options Held
2.51MPut Options Held
940K-
Morgan Stanley New York, NY41MShares$1.52 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.36 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$854 Million0.01% of portfolio
-
Baillie Gifford & CO18MShares$669 Million0.51% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$451 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...